{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:59:06Z","timestamp":1790431146725,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.mayocp.2018.10.022","type":"journal-article","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T09:08:04Z","timestamp":1544519284000},"page":"1261-1267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events"],"prefix":"10.1016","volume":"94","author":[{"given":"Daniele","family":"Pastori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Pignatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Menichelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Violi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mayocp.2018.10.022_bib1","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1160\/TH16-11-0876","article-title":"Stroke prevention in atrial fibrillation: past, present and future. Comparing the guidelines and practical decision-making","volume":"117","author":"Lip","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.mayocp.2018.10.022_bib2","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.amjmed.2016.06.045","article-title":"Causes of death and influencing factors in patients with atrial fibrillation","volume":"129","author":"Fauchier","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.mayocp.2018.10.022_bib3","doi-asserted-by":"crossref","first-page":"e002197","DOI":"10.1161\/JAHA.115.002197","article-title":"Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF","volume":"5","author":"Pokorney","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.mayocp.2018.10.022_bib4","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1378\/chest.15-1622","article-title":"Oral anticoagulation and the risk of stroke or death in patients with atrial fibrillation and one additional stroke risk factor: the Loire Valley Atrial Fibrillation Project","volume":"149","author":"Fauchier","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.mayocp.2018.10.022_bib5","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1161\/CIRCULATIONAHA.112.000491","article-title":"Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study","volume":"128","author":"Marijon","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.mayocp.2018.10.022_bib6","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1016\/j.jacc.2016.09.944","article-title":"Causes of death in anticoagulated patients with atrial fibrillation","volume":"68","author":"Gomez-Outes","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.mayocp.2018.10.022_bib7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/europace\/eux318","article-title":"Integrating new approaches to atrial fibrillation management: the 6th AFNET\/EHRA Consensus Conference","volume":"20","author":"Kotecha","year":"2018","journal-title":"Europace Cardiol"},{"key":"10.1016\/j.mayocp.2018.10.022_bib8","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1136\/heartjnl-2016-310952","article-title":"Integrated care in atrial fibrillation: a systematic review and meta-analysis","volume":"103","author":"Gallagher","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.mayocp.2018.10.022_bib9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrcardio.2017.153","article-title":"The ABC pathway: an integrated approach to improve AF management","volume":"14","author":"Lip","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.mayocp.2018.10.022_bib10","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1160\/TH17-08-0555","article-title":"Regional differences in antithrombotic treatment for atrial fibrillation: insights from the GLORIA-AF Phase II Registry","volume":"117","author":"Mazurek","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.mayocp.2018.10.022_bib11","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1160\/TH16-12-0961","article-title":"Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients","volume":"117","author":"Rivera-Caravaca","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.mayocp.2018.10.022_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejim.2018.04.007","article-title":"Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation","volume":"54","author":"Pastori","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.mayocp.2018.10.022_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.clinthera.2017.11.014","article-title":"Reduced time in therapeutic range and higher mortality in atrial fibrillation patients taking acenocoumarol","volume":"40","author":"Rivera-Caravaca","year":"2018","journal-title":"Clin Ther"},{"key":"10.1016\/j.mayocp.2018.10.022_bib14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ijcard.2015.08.054","article-title":"Inadequate anticoagulation by vitamin K antagonists is associated with major adverse cardiovascular events in patients with atrial fibrillation","volume":"201","author":"Pastori","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.mayocp.2018.10.022_bib15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.15420\/aer.2018.18.2","article-title":"Risk factor management in atrial fibrillation","volume":"7","author":"Brandes","year":"2018","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"10.1016\/j.mayocp.2018.10.022_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1160\/TH17-07-0492","article-title":"Atherothrombosis and thromboembolism: position paper from the Second Maastricht Consensus Conference on Thrombosis","volume":"118","author":"Spronk","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.mayocp.2018.10.022_bib17","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.amjmed.2018.06.012","article-title":"Improved outcomes by integrated care of anticoagulated patients with atrial fibrillation using the simple ABC (Atrial Fibrillation Better Care) pathway","volume":"131","author":"Proietti","year":"2018","journal-title":"Am J Med"},{"key":"10.1016\/j.mayocp.2018.10.022_bib18","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.mayocp.2018.01.028","article-title":"A\u00a0propensity score matched comparison of clinical outcomes in atrial fibrillation patients taking vitamin K antagonists: comparing the \"real-world\" vs clinical trials","volume":"93","author":"Rivera-Caravaca","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.mayocp.2018.10.022_bib19","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jacc.2017.07.743","article-title":"Relationship of PCSK9 and urinary thromboxane excretion to cardiovascular events in patients with atrial fibrillation","volume":"70","author":"Pastori","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.mayocp.2018.10.022_bib20","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.14-2414","article-title":"Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors","volume":"147","author":"Pastori","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.mayocp.2018.10.022_bib21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A\u00a0method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.mayocp.2018.10.022_bib22","series-title":"Atrial Fibrillation: The Management of Atrial Fibrillation","year":"2014"},{"key":"10.1016\/j.mayocp.2018.10.022_bib23","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mayocp.2018.10.022_bib24","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1097\/HJH.0b013e328364ca4c","article-title":"2013 practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH\/ESC Task Force for the Management of Arterial Hypertension","volume":"31","author":"Mancia","year":"2013","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.mayocp.2018.10.022_bib25","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"Ryden","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mayocp.2018.10.022_bib26","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs033","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.mayocp.2018.10.022_bib27","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1160\/TH14-10-0859","article-title":"Safety and efficacy of well managed warfarin: a report from the Swedish quality register Auricula","volume":"113","author":"Sjogren","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.mayocp.2018.10.022_bib28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/CIRCOUTCOMES.114.001303","article-title":"Association between atrial fibrillation symptoms, quality of life, and patient outcomes: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)","volume":"8","author":"Freeman","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.mayocp.2018.10.022_bib29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/ehjqcco\/qcw031","article-title":"Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: results from the PREFER in AF registry","volume":"2","author":"Bakhai","year":"2016","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.mayocp.2018.10.022_bib30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.amjmed.2014.11.026","article-title":"Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry","volume":"128","author":"Boriani","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.mayocp.2018.10.022_bib31","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/eurheartj\/ehl504","article-title":"Effect of hypertension on anticoagulated patients with atrial fibrillation","volume":"28","author":"Lip","year":"2007","journal-title":"Eur Heart J"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619618308917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619618308917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T11:21:27Z","timestamp":1775301687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619618308917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0025619618308917"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.10.022","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}